KRISHGEN BIOSYSTEMS  

Pharmacokinetics (PK) describes what the human body does to a given pharmaceutical, from the time of administration to absorption,
distribution, metabolism, and excretion from the body. By assessing PK of a biological drug in different samples, including serum, plasma, urine, and saliva, we can understand a drug’s interaction with the body, as well as the intensity and duration of its efficacy.
Understanding the pharmacokinetic and pharmacodynamic behavior of a given therapeutic drug is an essential element of
understanding its effectiveness and safety, as well as identifying the proper dosage, combinations and distribution.

KRISHGEN offers kits in an easy to use ELISA format, which are ready-to-use and well validated. These ELISA are unique assays for estimation of therapeutic drugs specific for free drug, bound drug or partially bound / total drug estimation.... More Info Less Info

The range of Pharmacokinetics (PK) ELISA Kits for the quantification of serum and plasma protein drug levels to provide
accurate pharmacokinetic (PK) data that will help optimize drug dosing regimens. These mAb-based ELISA are
developed for use with biosimilars and biologics. These are specific, validated assays for detection of monoclonal antibody
drugs for pharmacokinetic studies and therapeutic drug monitoring. ... More Info Less Info

Bispecific antibodies, as the name suggests, are antibodies with two binding sites – directed against two different antigens, or in some cases, two different epitopes on the same antigen. BsAbs have been shown to be clinically superior to monoclonal antibodies in their specificity and have a wide range of the therapeutic application under tumor and other diseases. Their clear advantage is the enhanced specificity target - ability and reduced off-target toxicity they allow for. Krishgen offer a range of ELISA to quantify bispecific antibody drug levels accurately and quickly in serum and plasma samples. 
 ... More Info Less Info